Treatment of xerostomia with polymer-based saliva substitutes in patients with Sjögren's syndrome

Arthritis and Rheumatism

Volumn 39, Issue 1, 1996, Pages 57-63

  Van Der Reijden, Willy A ^a   Van Der Kwaak, Hanneke ^a   Vissink, Arjan ^b   Veerman, Enno C I ^a   Nieuw Amerongen, Arie V ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

POLYACRYLIC ACID; SALIVA SUBSTITUTE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SALIVATION; SJOEGREN SYNDROME; VISCOELASTICITY; XEROSTOMIA;

ACRYLIC RESINS; ADULT; AGED; ANIMALS; DOUBLE-BLIND METHOD; FEMALE; GASTRIC MUCIN; HUMANS; MALE; MIDDLE AGED; POLYSACCHARIDES, BACTERIAL; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SJOGREN'S SYNDROME; SWINE; TREATMENT OUTCOME; XEROSTOMIA;

EID: 0030058128     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780390108     Document Type: Article

References (31)

1. Moutsopoulos HM, Chused TM, Mann DL, Klippel JH, Fauci AS, Frank MM, Lawley TJ, Hamberger MI: Sjögren's syndrome (sicca syndrome): current issues. Ann Intern Med 92: 212-226, 1980
2. Fox PC, Atkinson JC, Macynski AA, Wolff A, Kung DS, Valdez IH, Jackson W, Delaphena RA, Shiroky J, Baum BJ: Pilocarpine treatment of salivary gland hypofunction and dry mouth (xerostomia). Arch Intern Med 151:1149-1152, 1991
3. Björnström M, Axéll T, Birkhed D: Comparison between saliva stimulants and saliva substitutes in patients with symptoms related to dry mouth. Swed Dent J 14:153-161, 1990
4. Shiozawa S, Morimoto I, Tanaka Y, Shiozawa K: A preliminary study on the interferon-alpha treatment for xerostomia of Sjögren's syndrome. Br J Rheumatol 32:52-54, 1993
5. Talal N, Quinn JH, Daniels TE: The clinical effects of electrostimulation on salivary function of Sjögren's syndrome patients. Rheumatol Int 12:43-45, 1992
6. Vissink A, Waterman HA, 's-Gravenmade EJ, Panders AK, Vermey A: Rheological properties of saliva substitutes containing mucin, carboxymethylcellulose orpolyethyleneoxide. J Oral Pathol 13:22-28, 1984
7. Vissink A, de Jong HP, Busscher HJ, Arends J, 's-Gravenmade EJ: Wetting properties of human saliva and saliva substitutes. J Dent Res 65:1121-1124, 1986
8. Hatton MN, Levine MJ, Margarone JE, Aguirre A: Lubrication and viscosity features of human saliva and commercially available saliva substitutes. J Oral Maxillofacial Surg 45:496-499, 1987
9. Veerman ECI, Valentijn-Benz M, Nieuw Amerongen AV: Viscosity of human salivary mucins: effect of pH and ionic strength and role of sialic acid. J Biol Buccale 17:297-306, 1989
10. McCullagh CM, Soby LM, Jamieson AM, Blackwell J: Viscoelastic behavior of fractionated ovine submaxillary mucins. Biopolymers 32:1665-1674, 1992
11. Van der Reijden WA, Veerman ECI, Nieuw Amerongen AV: Shear rate dependent viscoelastic behavior of human glandular salivas. Biorheol 30:141-152, 1993
12. Nieuw Amerongen AV, Oderkerk CH, Driessen AA: Role of mucins from human whole saliva in the protection of tooth enamel against demineralization in vitro. Caries Res 21:297-309, 1987
13. Nieuw Amerongen AV, Oderkerk CH, Veerman ECI: Interaction of human salivary mucins with hydroxyapatite. J Biol Buccale 17:85-92, 1989
14. Matzker J, Schreiber J: Synthetischer Speichel zur Therapie der Hyposialien insbesondere bei der radiogenen Sialadenitis. Z Laryngol Rhinol Otol 51:422-428, 1972
15. 's-Gravenmade EJ, Roukema PA, Panders AK: The effect of mucin-containing artificial saliva on severe xerostomia. Int J Oral Surg 3:435-439, 1974
16. Roberts BJ: Help for the dry mouth patient. J Dent 10:226-234, 1982
17. Vissink A, 's-Gravenmade EJ, Panders AK, Vermey A, Petersen JK, Visch LL, Schaub RMH: A clinical comparison between commercially available mucin- and CMC-containing saliva substitutes. Int J Oral Surg 13:435-439, 1983
18. Mellema J, Holterman HJ, Waterman HA, Blom C: Rheological aspects of mucin-containing solutions and saliva substitutes. Biorheol 29:231-249, 1992
19. Van der Reijden WA, Veerman ECI, Nieuw Amerongen AV: Rheological properties of commercially available polysaccharides with potential use in saliva substitutes. Biorheol 31:631-642, 1994
20. Olsson H, Axéll T, Carlsson A, Bogentoft C: Objective and subjective efficacy evaluation of various polymer-based saliva substitutes. Scand J Dent Res 101:37-39, 1993
21. Klestov AC, Webb J, Latt D, Schiller G, McNamara K, Young DY, Nobbes J, Fetherston J: Treatment of xerostomia: a double blind trial in 108 patients with Sjögren's syndrome. Oral Surg Oral Med Oral Pathol 51:594-599, 1981
22. Wiesenfeld D, Stewart AM, Mason DK: A critical assessment of oral lubricants in patients with xerostomia. Br Dent J 155:155-157, 1983
23. Visch LL, 's-Gravenmade EJ, Schaub RMH, Van Putten WLJ, Vissink A: A double-blind crossover trial of CMC- and mucin-containing saliva substitutes. Int J Oral Maxillofac Surg 15:395-400, 1986
24. Vissink A, Schaub RMH, van Rijn LJ, 's-Gravenmade EJ, Panders AK, Vermey A: The efficacy of mucin-containing artificial saliva in alleviating symptoms of xerostomia. Gerodont 6:95-101, 1987
25. 's-Gravenmade EJ, Vissink A: Mucin-containing lozenges in the treatment of intraoral problems associated with Sjögren's syndrome. Oral Surg Oral Med Oral Pathol 75:466-471, 1993
26. Aagaard A, Godiksen S, Teglers PT, Schiødt M, Glenert U: Comparison between new saliva stimulants in patients with dry mouth: a placebo controlled double-blind crossover study. J Oral Pathol Med 21:376-380, 1992
27. Van der Reijden WA, Veerman ECI, Nieuw Amerongen AV: Use of natural and synthetic polymers as mucin-substitutes in artificial salivas (abstract no. P37). In, Proceedings of the Twelfth Polymer Networks Group Conference of the IUPAC, July 25-29, 1994, Prague, Czech Republic
28. Gu J-M, Robinson JR, Leung S-HS: Binding of acrylic polymers to mucin/epithelial surfaces: structure-property relationships. Crit Rev Ther Drug Carrier Syst 5:21-67, 1988
29. Jabbari E, Wisniewski N, Peppas NA: Evidence of mucoadhesion by chain interpenetration at a poly(acrylic acid)/mucin interface using ATR-FTIR spectroscopy. J Controlled Release 26:99-108, 1993
30. Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM, Bjerrum KB, Braga S, Coll J, de Vita S, Drosos AA, Ehrenfeld M, Hatron PY, Hay EM, Isenberg DA, Janin A, Kalden JR, Kater L, Konttinen YT, Maddison PJ, Maini RN, Manthorpe R, Meyer O, Ostuni P, Pennec Y, Prause JU, Richards A, Sauvezie B, Schiødt M, Sciuto M, Scully C, Shoenfeld Y, Skopouli FN, Smolen JS, Snaith ML, Tishler M, Todesco S, Valesini G, Venables PJW, Wattiaux MJ, Youinou P: Preliminary criteria for the classification of Sjögren's syndrome: results of a prospective concerted action supported by the European Community. Arthritis Rheum 36:340-347, 1993
31. Duxbury AJ, Thakker NS, Wastell DG: A double blind crossover trial of a mucin-containing artificial saliva. Br Dent J 166:115-120, 1989